COMP <GO>
BRSL vs GENI // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Brightstar Lottery PLC Trading under the Legal Name to begin at the market open on July 21 2025. (NYSE) VS. Genius Sports Limited (NYSE) • 15-METRIC TALLY: BRSL 3
— GENI 4
■ METRIC PARITY
BRSL — Brightstar Lottery PLC Trading under the Legal Name to begin at the market open on July 21 2025.
ROARABLE E • RQD 34/100
LAST: $9.60 (+3.34%) • MKT CAP: $1.77B
options-implied-move
—
LAST: $6.46 (+1.73%) • MKT CAP: $1.73B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BRSL VS. GENI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BRSL | GENI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 23.00% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.80% | -26.90% | +43.70 | BRSL | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -5.59% | 3.73% | -9.32 | GENI | /fcf-yield <GO> |
| Operating Margin | — | -22.60% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 5.90% | -16.70% | +22.60 | BRSL | /net-margins <GO> |
| Revenue Growth (YoY) | 0.00% | 31.00% | -31.00 | GENI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 1.43 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 5/9 | -4.00 | GENI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.2 | 50.2 | -5.00 | GENI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 11.2x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.77B | $1.73B | $42.3M | BRSL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BRSL REV | GENI REV | BRSL GROSS % | GENI GROSS % | BRSL FCF | GENI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.51B | $669.5M | — | 23.0% | -$99.0M | $64.5M |
| FY 2024 | $2.51B | $510.9M | — | 25.2% | $1.05B | $69.6M |
| FY 2023 | $2.53B | $413.0M | — | — | $1.01B | $14.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BRSL // BETA —
GENI // BETA —